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Literature model
The literature MILP model 19 for the optimal chromatography strategies of antibody purification processes is presented as follows.
The integer variables, , and , are expressed by binary variables: For each packed-bed chromatography step, only one resin can be used:
At most one resin of each resin type can be used:
The initial product protein mass, 0 , is the protein mass from the upstream bioreactors:
The product protein mass remaining after step s, is related to the yield of the step:
The annual product output, , is amount of product produced per year by the facility:
The number of completed batches, , is limited by an upper bound:
The total column volume of chromatography step s, , is the number of columns, , multiplied by the single column volume, :
Only one column size is allowed at each chromatography step.
The total amount of resin available is no less than the minimum required amount, :
The number of cycles, , at each chromatography step has an upper bound:
Volumetric flow rate, , is determined by the velocity of flow and the diameter of the column:
The initial product volume entering downstream processes, 0 , is the working volume of bioreactor:
The product volume remaining after each step s, , and the required buffer material volume at each step s, , are given in Eq. (A30)-(S.43):
The total buffer usage per batch, , is the summation of buffer usage, , in all downstream steps:
The annual total buffer volume, , is related to the number of completed batches:
The total processing time at each chromatography step, , is comprised of processing time for both adding buffer ( ) and loading product ( ):
The processing time for loading product, is related to the incoming product volume:
The processing time for adding buffer, is related to the required buffer volume:
The processing time per batch, , is the summation of processing time of all downstream steps:
The annual DSP time, , is related to the number of completed batches:
The annual DSP time, , cannot exceed the annual available time:
The labour cost, , involves the direct labour cost, , supervisors cost, , quality control and quality assurance (QCQA) cost, , and management cost, :
The chemical reagents cost, , is assumed to include the cost for buffer, , and bioreactor media, :
The key consumables cost, , in this study is the resin cost: The miscellaneous material cost, , is proportional to the total chemical reagents cost, , and consumables cost, .
The utilities cost, , can be expressed as the summation of three terms:
The annualised capital cost, , is calculated by the fixed capital investment, , and the capital recovery factor:
Other indirect costs include the annual maintenance cost, , insurance cost, , local tax costs, , and general utilities cost, : The annual total cost of goods is the summation of the above costs:
The objective is to minimise COG/g: Lang factor maximum buffer volume per batch maximum number of batches maximum bioreactor volume maximum number of columns at chromatography step s maximum column volume at chromatography step s maximum number of cycles at chromatography step s maximum product volume at step s maintenance cost ratio to the fixed capital investment media price, £/L miscellaneous material cost ratio to chemical reagent and consumable costs management cost ratio to direct labour cost product yield of non-chromatography step s neutralisation volume ratio of step s other equipment cost ratio to the bioreactor cost of overpacking factor of resin maximum digit number in the binary representation of number of batches, ⌈log 2 ⌉ QCQA cost ratio to direct labour cost interest rate resin price of resin r, £/L reference cost of a bioreactor, £ reference volume of a bioreactor, L reference cost of a chromatography column, £ reference diameter of a chromatography column, cm duration per shift, hour number of shifts per day seed train bioreaction time, day supervisors cost ratio to direct labour cost upstream product titre, g/L tax cost ratio to the fixed capital investment number of operators per bioreactor in upstream processing linear velocity of flow for resin r, cm/h wage of an operator, £/h bioreactor working volume ratio media overfill allowance chromatography resin utilisation factor batch success rate 
Continuous
Case study data
More data of the case study are presented in Tables S1 and S2 . 
